Biotech Vac will participate in a special episode of the TV series Advancements

The innovative vaccine to prevent salmonella in Vetanco’s birds will be part of an upcoming segment of the award-winning series “Advancements” with Ted Danson, which will focus on the latest advances in vaccine science.

Next Saturday, February 25th, at 8 PM, Biotech Vac, the first vaccine in the world using subunits technology in poultry farming and the only one providing protection against several strains and serotypes of salmonella, developed by Vetanco, will participate in the TV series “Advancements”, hosted by Ted Danson, in a special episode in which we are invited to discover how science and technology work together to promote innovation.

This segment will explore the advances in the poultry industry that help to mitigate the risk of food-borne diseases, such as salmonellosis in humans. The audience will learn how the introduction of Biotech Vac – Salmonella in South America will provide the poultry immunologic protection against all motile species of Salmonella.

The viewers will learn how Biotech Vac allows the protection of several hosts of pathogen families in an effort to stop the transmission to and from humans, animals, birds, fish, etc.

There are more than 2600 serovars of Salmonella enterica bacteria; not all of them affect humans, but trying to aim individually to serovars representing a risk of food-borne diseases is a Whack-a-mole game. The technology Biotech Vac Salmonella Platform was an international effort for designing a strategy to control salmonellosis in humans,” said Sherry Layton, Ph.D. International Scientific Director of Vetanco.

In addition, the program will explore how the platform enables the options “plug and play”, that allow itself to quickly update as new diseases arise, which reduces significantly the time to market.

“The science behind Biotech Vac is a combination of comparative genomics and proteomics along with synthetic biology. Those 2600 serovars have a central proteome and we have identified preserved protecting antigens with which we then clone and produce a Bacillus, a factory of natural proteins completely innocuous but highly efficient. Once the antigens are produced and formulated, we can administer the vaccine to the animal efficiently,” added Layton.

By doing things differently, the platform is helping to clear the doubts and worries of consumers about the reaction to vaccine and reversion to virulence”, commented Colin Ferguson, senior producer of the series Advancements. “We expect to look into this in the program”.

The episode will be broadcasted through Bloomberg, by the TV and satellite providers, and then by Amazon Prime Video.

About Advancements and DMG Productions

Advancements is an educative TV series based on information that explores the latest developments taking place in different industries and economies. By bringing light on important issues and topics that affect today’s society, the series present major improvements, modern technology, and innovative solutions responsible for shaping, modelling, and transforming our world.

With the support of experts in several fields, DMG Productions dedicates to education and development, and to constantly produce educative programming without ads for viewers and broadcasters.

For more information, please visit www.AdvancementsTV.com

Leave a Reply

Your email address will not be published. Required fields are marked *